|
About ACRF Centre for Therapeutic Target Discovery
|
The ACRF Centre for Therapeutic Target Discovery is a formally constituted, inter-institution collaboration designed to
maximise shared resources (both human and material) for the purpose of conducting highly innovative cancer research.
It forms the scientific cornerstone of the first Comprehensive Cancer Centre established in Australia.
The ACRF Centre for Therapeutic Target Discovery created on the Royal Melbourne Hospital Parkville Campus has
resulted from growing recognition of the need for an integrated approach to cancer service delivery and basic, translational
and clinical research. The consortium that launched the initial phase of the MCCC includes the Royal Melbourne Hospital
(Melbourne Health), Royal Women's Hospital, The Ludwig Institute for Cancer Research (Parkville campus), The Walter and
Eliza Hall Institute of Medical Research, and The University of Melbourne.
The unifying theme for the ACRF Centre for Therapeutic Target Discovery is to address issues in cancer biology from novel
and previously unexplored research perspectives, which have only recently become accessible through technological
advances and exciting new paradigms in cancer biology. In a systematic fashion, we hope to identify the key cellular
components within tumours, and the key signalling elements within cancer cells, that sustain the cancer's malignant
potential. These should represent excellent candidates for targeted drug discovery.
|
|
|
The ACRF Centre for Therapeutic Target Discovery
was launched by a generous donation from the ACRF in 2006.
The ACRF CTTD was official opened January 29th 2009 - read about this event
|
|
|
|
|
